Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|June 11, 2016
Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus InfectionSwee Lin G Chen Yi Mei, Jodie Burchell, Narelle Skinner, et al.
Kidney International|April 13, 2012
Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccinationWilliam R Mulley, Kumar Visvanathan, Aeron C Hurt, et al.
Internal Medicine Journal|August 11, 2025
Effective real-world outcomes of remdesivir provided under compassionate access for moderate/severe COVID-19 in AustraliaRobert Stolz, Alice Liu, Jonathan Darby, et al.
Gut|October 18, 2015
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leadersKumar Visvanathan, Geoff Dusheiko, Michelle Giles, et al.
Hepatology (Baltimore, Md.)|March 11, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis BEdward J Gane, Hyung Joon Kim, Kumar Visvanathan, et al.
Journal of Viral Hepatitis|March 4, 2021
A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in AustraliaYinzong Xiao, Jack Wallace, Alex Thompson, et al.
Hepatology Communications|March 30, 2023
A novel point-of-care test for cirrhosis based on dimeric to monomeric IgA ratio in blood: a pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
Clinical & Translational Immunology|September 21, 2020
CD8+ tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survivalRosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Kidney International|September 17, 2010
Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritisShaun A Summers, Betty S van der Veen, Kim M O'Sullivan, et al.
The Lancet. Gastroenterology & Hepatology|November 13, 2019
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trialMan-Fung Yuen, Kosh Agarwal, Edward J Gane, et al.
Pageof 8